Blueshift Asset Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding RGNX
RG
RI
ACM
SI
Blueshift Asset Management's RGNX Position: Q2 2022 in Review
Blueshift Asset Management sold out of Regenxbio (RGNX) in Q2 2022, closing a stake of 12,104 shares — an estimated $402K sold.
Blueshift Asset Management first reported a position in RGNX in Q4 2018 and held it in 3 quarters. The position peaked at $441K in Q2 2021. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2022.
- Blueshift Asset Management reported no remaining Regenxbio position as of Q2 2022 after selling out during the quarter.
- Blueshift Asset Management sold 12,104 Regenxbio shares in Q2 2022, an estimated $402K.
- Blueshift Asset Management first reported a position in Regenxbio in Q4 2018 and held it in 3 quarters.
- Blueshift Asset Management's Regenxbio position peaked at $441K in Q2 2021.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2022.
Based on Blueshift Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.